In 2023, Charles (Chas) McKhann earned $8.26M in total compensation at Silk Road Medical, including $650.00K salary, $93.28K bonus and $7.51M in stock. Most recently acquired 5,196,168 shares in Sep 2024. 2+ years at the helm of Silk Road Medical.
Compensation History
Annual executive compensation data for Charles (Chas) McKhann, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$8.26M
Salary
$650.00K
Bonus
$93.28K
Other
$1.63K
Salary
$650.00KBoard Justification
The compensation philosophy aligns with company performance, emphasizing pay-for-performance and competitive compensation packages to attract and retain top talent.
Bonus
$93.28KBoard Justification
The target bonus opportunity for our new CEO was set at 100% of his base salary, prorated for 2023, based on performance metrics including revenue growth, operating expense management, and gross margin.
Other Compensation
$1.63KBoard Justification
Includes 401(k) match and other benefits.
Restricted Stock
Board Justification
The stock of the CEO that vested in 2023 includes 612,083 RSUs granted as part of his new hire compensation package, which vest annually over four years, subject to continued service.
Performance Metrics
The performance metrics for the 2023 bonus plan included revenue growth over 2022, operating expense management, and gross margin.
Charles (Chas) McKhann
CEO of Silk Road Medical
Education
B.A. in Political Sciences and Economics and M.B.A. from Stanford University
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
January 1, 1969 - 56 years ago
CEO of Silk Road Medical for
2 years 1 month (Nov 2023 - Present)
Previous Experience
CEO of Apollo Endosurgery, Inc. and various roles in medical device companies
Other Silk Road Medical CEOs
Holdings
Track Charles (Chas) McKhann's stock holdings and portfolio value over time.
Insider Trading
Charles (Chas) McKhann's recent stock transactions, purchases, and sales filed with the SEC.
5,196,168 shares
SILK
Sep 17, 2024
Received
110,313 shares
SILK
Mar 1, 2024
Received
612,083 shares
SILK
Nov 2, 2023
Received
Rivals
Compare Charles (Chas) McKhann with competitor CEOs and industry peers.